𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Next Generation of Immunotherapy for Melanoma

✍ Scribed by Kirkwood, J. M.; Tarhini, A. A.; Panelli, M. C.; Moschos, S. J.; Zarour, H. M.; Butterfield, L. H.; Gogas, H. J.

Book ID
118044202
Publisher
American Society of Clinical Oncology
Year
2008
Tongue
English
Weight
352 KB
Volume
26
Category
Article
ISSN
0732-183X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Immunotherapy for melanoma
Immunotherapy for melanoma
✍ Lacy, Katie E; Karagiannis, Sophia N; Nestle, Frank O πŸ“‚ Article πŸ“… 2012 πŸ› Expert Reviews 🌐 English βš– 714 KB
Immunotherapy for melanoma
Immunotherapy for melanoma
✍ Ian Komenaka; Heidi Hoerig; Howard L Kaufman πŸ“‚ Article πŸ“… 2004 πŸ› Elsevier Science 🌐 English βš– 306 KB
Immunotherapy for metastatic melanoma
Immunotherapy for metastatic melanoma
✍ Christopher R. Zito; Harriet M. Kluger πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 118 KB

## Abstract Melanoma has traditionally been considered an immunogenic tumor. A number of approaches have been studied for enhancement of antitumor immunity. The first cytokine approved for the treatment of metastatic melanoma, interleukin‐2, has resulted in prolonged responses in a small subset of

Adjuvant immunotherapy for melanoma
Adjuvant immunotherapy for melanoma
✍ L. J. Humphrey; S. Taschler-Collins; P. M. Coldfarb; O. Sincla; F. J. Volenec πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 282 KB

Adjuvant immunotherapy was administered to 84 lymph-node-negative and 25 lymph-node-positive melanoma patients. This active specific homologous cell protein preparation was given after aggressive surgery and given over 2 years. Projected and observed survival rates are presented as well as other cli